4.4 Article

Hsp90 inhibitors reduce influenza virus replication in cell culture

Journal

VIROLOGY
Volume 377, Issue 2, Pages 431-439

Publisher

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.virol.2008.04.040

Keywords

influenza viruses replication; RNA polymerase; Hsp90; geldanamycin; 17 AAG; antiviral agents

Categories

Funding

  1. Medical Research Council [G117/457, G9523972, G9826944, G9901312, G0700848] Funding Source: Medline
  2. MRC [G0700848, G9826944, G9523972, G117/457] Funding Source: UKRI
  3. Medical Research Council [G9826944, G9523972, G0700848, G117/457] Funding Source: researchfish

Ask authors/readers for more resources

The viral RNA polymerase complex of influenza A virus consists of three subunits PB1, PB2 and PA. Recently, the cellular chaperone Hsp90 was shown to play a role in nuclear import and assembly of the trimeric polymerase complex by binding to PB1 and PB2. Here we show that Hsp90 inhibitors, geldanamycin or its derivative 17-AAG, delay the growth of influenza virus in cell culture resulting in a 1-2 log reduction in viral titre early in infection. We suggest that this is caused by the reduced half-life of PB1 and PB2 and inhibition of nuclear import of PB1 and PA which lead to reduction in viral RNP assembly. Hsp90 inhibitors may represent a new class of antiviral compounds against influenza viruses. (C) 2008 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available